These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10461821)

  • 21. Phenomenology and treatment of selective mutism.
    Kumpulainen K
    CNS Drugs; 2002; 16(3):175-80. PubMed ID: 11888338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenelzine therapy for headache patients with concomitant depression and anxiety.
    Turkewitz LJ; Casaly JS; Dawson GA; Wirth O
    Headache; 1992 Apr; 32(4):203-7. PubMed ID: 1582841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenelzine: legacy or current psychiatric practice?].
    Marini S; Serata D; Brugnoli R
    Clin Ter; 2013; 164(3):e211-22. PubMed ID: 23868641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Examination of Fluoxetine for the Treatment of Selective Mutism Using a Nonconcurrent Multiple-Baseline Single-Case Design Across 5 Cases.
    Barterian JA; Sanchez JM; Magen J; Siroky AK; Mash BL; Carlson JS
    J Psychiatr Pract; 2018 Jan; 24(1):2-14. PubMed ID: 29320378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoamine oxidase inhibitors: various clinical remarks on phenelzine].
    Guyotat J; Favre-Tissot M; Marie-Cardine M
    J Med Lyon; 1966 Jun; 47(101):1009-15. PubMed ID: 4914860
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of cocaine abuse with monoamine oxidase inhibitors.
    Brewer C
    Br J Psychiatry; 1993 Dec; 163():815-6. PubMed ID: 8306127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract]   [Full Text] [Related]  

  • 30. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.
    Gracious BL; Wisner KL
    Depress Anxiety; 1997; 6(3):124-8. PubMed ID: 9442987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG; Quitkin FM; McGrath P; Harrison W; Tricamo E
    J Clin Psychopharmacol; 1985 Feb; 5(1):2-9. PubMed ID: 3973068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential interactions between monoamine oxidase inhibitors and prescribed dietary supplements.
    Sweet RA; Liebowitz MR; Holt CS; Heimberg RG
    J Clin Psychopharmacol; 1991 Oct; 11(5):331-2. PubMed ID: 1765578
    [No Abstract]   [Full Text] [Related]  

  • 36. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM; Masica DN; Heiligenstein JH; Wheadon DE; Zerbe RL
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamine Oxidase Inhibitors for Trichotillomania: A Case Series.
    Grant JE; Chamberlain SR
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):149-151. PubMed ID: 36700727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modafinil augmentation of phenelzine for residual fatigue in dysthymia.
    Ashton AK
    Am J Psychiatry; 2004 Sep; 161(9):1716-7. PubMed ID: 15337670
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin syndrome probably triggered by a morphine-phenelzine interaction.
    Mateo-Carrasco H; Muñoz-Aguilera EM; García-Torrecillas JM; Abu Al-Robb H
    Pharmacotherapy; 2015 Jun; 35(6):e102-5. PubMed ID: 25903219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.